GlassScriptPhysician profile
Hannah Thomson Hoopes
NPI 1134682768
$11,411.82
in general payments reported to CMS, 2019-2025
12 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,545 · 2021: $1,224 · 2022: $1,299 · 2023: $1,217 · 2024: $977 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,310 · Travel and Lodging: $33.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,310.15 |
| Travel and Lodging | $33.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $8,160.18 | 2019-2024 | |
| Stryker Corporation | $1,841.11 | 2021-2024 | Mako, Axsos, T2 |
| Medical Device Business Services, INC. | $867.70 | 2019 | |
| Orthofix Medical, INC. | $232.43 | 2024 | Truelok, Tl-Hex Truelok Hexapod System |
| Xeris Pharmaceuticals, INC. | $123.83 | 2025 | Gvoke Hypopen |
| Smith+Nephew, INC. | $50.43 | 2024 | Evos, Trigen Intertan, Trigen |
| Kci USA, INC. | $39.63 | 2019-2023 | V.A.C.Ulta, Prevena |
| Orthopediatrics Corp. | $33.93 | 2024 | |
| Polynovo North America LLC | $28.95 | 2024 | Novosorb Btm |
| Zimmer Biomet Holdings, INC. | $17.07 | 2025 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Biocomposites INC | $8.96 | 2025 | Stimulan |
| Depuy Synthes Sales INC. | $7.60 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Hoopes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.